Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › ARWR

DEERFIELD MANAGEMENT COMPANY, L.P. position in ARWR

ARROWHEAD PHARMACEUTICALS IN · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 1,389,055 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$113.2M, representing 1.42% of its reported portfolio and ranking #19 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed ARWR holdings in 6 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)1.39M sh
Reported value held$113.22M
Portfolio Weight1.42%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s ARWR position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in ARWR in Q2 2024 at 19,461 shares (US$506K). The position peaked in Q4 2025 at 1,832,946 shares, worth US$121.7M. Across 6 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,389,055 shares valued at US$113.2M — a reduction of -184,242 shares quarter over quarter.. Notable position changes include a 36% increase in Q3 2024 (shares fell 3% over the following quarter), a 85% increase in Q4 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 19.46K $505.79K New
Q3 2024 26.44K $512.12K Add
Q3 2025 993.00K $34.25M New
Q4 2025 1.83M $121.69M Add
Q1 2026 1.57M $98.65M Reduce
Q2 2026 1.39M $113.22M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARWR and 13F data

ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 52 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARWR

All ARWR fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held ARWR?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed ARWR holdings in 6 of the last 9 reported quarters, going back to Q2 2024.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in ARWR?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 1.39M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $113.22M, representing 1.42% of its reported portfolio and ranking #19.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling ARWR?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. reduced its position in ARWR. The position peaked in Q4 2025 at 1.83M shares.

Which other funds hold ARWR?

Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.